OTC · Medical - Instruments & Supplies

HOYA Corporation (HOCPY) Stock

$164.10 +2.01% OTC: HOCPY Healthcare

Established in Tokyo, Japan, in 1941, HOYA Corporation operates as a global med-tech enterprise and a leading provider of advanced technological and medical solutions. Its extensive "life care" division offers a diverse portfolio, ranging from ophthalmic products like eyeglasses and contact lenses to sophisticated medical instruments such as endoscopes, intraocular lenses, laparoscopic surgical tools, and automated endoscope cleaning systems.

Valuation

MetricValue
Price$164.10
Market Cap$54.89B
P/E Ratio32.45
P/B Ratio8.45
P/S Ratio8.72
EPS (TTM)$5.06
52-Week High$190.18
52-Week Low$128.51
Dividend Yield1.25%

Financials & Margins

MetricValue
ROE26.25%
ROA20.51%
ROCE26.77%
Gross Margin78.90%
Operating Margin30.18%
Net Margin27.16%
Debt/Equity0.04
Current Ratio4.91

Annual Financials (USD)

Metric20222023202420252026
Revenue$670.3B$734.1B$762.6B$885.8B$1.00T
Operating Profit$317.0B$346.4B$353.8B$480.8B$297.3B
Net Profit$164.5B$168.6B$181.4B$202.1B$268.3B
EPS$445.93$469.47$515.27$581.26$789.31
Op Margin47.3%47.2%46.4%54.3%29.6%

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$992.8B$1.03T$1.20T$1.23T$1.31T
Total Liabilities$203.8B$213.7B$241.4B$262.6B$267.0B
Cash$419.4B$405.9B$525.2B$534.0B$576.6B
Borrowings$21.6B$24.6B$29.2B$37.3B$42.4B

Latest News

HAYW or HOCPY: Which Is the Better Value Stock Right Now? Zacks · Aug 4, 2026 Hoya (TSE:7741) Stock After New FDA Clearance Weighing Rich Valuation Against Growth Potential Simply Wall St. · Jun 14, 2026 Hoya (TSE:7741) Stock After 60% Rise Is The Rally Losing Steam? Simply Wall St. · Jun 14, 2026 [Latest] Global Gastrointestinal Endoscopy Devices Market Size/Share Worth USD 19.6 Billion by 2035 at a 5.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis) GlobeNewswire · Jun 10, 2026 DKILY vs. HOCPY: Which Stock Is the Better Value Option? Zacks · May 14, 2026

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$190.1B$201.8B$222.8B$235.1B$295.2B
Investing Cash Flow$-58.2B$-81.0B$-76.9B$-81.1B$-68.0B
Financing Cash Flow$-73.9B$-155.2B$-72.1B$-161.7B$-193.8B
Net Cash Flow$84.5B$-13.5B$119.3B$8.8B$6.1B
Free Cash Flow$161.2B$168.4B$181.7B$187.2B$235.2B

Valuation & Return Ratios

MetricValue
PEG Ratio1.01
EV / EBITDA19.91
FCF Yield2.75%
Quick Ratio4.20
Interest Coverage150.90
Return 1Y9.00%
Return 3Y57.16%
Return 5Y5.53%

Ownership

Insiders Held0.00%
Institutions Held0.06%
Institutions Float Held0.06%
Institutional HolderSharesReport Date
Ramirez Asset Management, Inc.20,7072026-03-31
Boston Common Asset Management, LLC42,0522026-06-30
Rhumbline Advisers8,5112026-03-31
Ancora Advisors, LLC852026-03-31
Gamma Investing LLC2,4182026-06-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALCAlcon Inc. $64.11 +1.55% 50.34 $31.27B 0.55%
BLCOBausch + Lomb Corporation $17.30 +0.87% -35.85 $6.18B 0.00%
COOThe Cooper Companies, Inc. $54.37 +0.13% 19.29 $10.60B 0.00%
CZMWYCarl Zeiss Meditec AG $35.36 +0.60% 22.43 $3.10B 1.80%
ESLOYEssilorLuxottica S.A. $98.62 -1.15% 31.71 $90.65B 2.35%

About HOYA Corporation

Established in Tokyo, Japan, in 1941, HOYA Corporation operates as a global med-tech enterprise and a leading provider of advanced technological and medical solutions. Its extensive "life care" division offers a diverse portfolio, ranging from ophthalmic products like eyeglasses and contact lenses to sophisticated medical instruments such as endoscopes, intraocular lenses, laparoscopic surgical tools, and automated endoscope cleaning systems. This segment also supplies various medical-related items, including prosthetic ceramic fillers and metallic implants. Furthermore, HOYA manages Eyecity, a specialized retail chain for contact lenses. Beyond healthcare, the company is a significant contributor to the information technology sector, manufacturing critical components like mask blanks and photomasks for semiconductor and liquid crystal display production, as well as glass disks for hard disk drives. Their imaging product range encompasses optical glasses, lenses, colored glass filters, and laser/UV light resources. Additionally, HOYA develops software solutions, notably ReadSpeaker for speech synthesis, and provides cloud-based services such as Kinnosuke for time and attendance management, and Yonosuke for electronic payslip distribution.

HOYA Corporation is headquartered in JP.

HOYA Corporation (HOCPY) stock trades at $164.10 with a market capitalization of $54.89B. The stock is valued at a price-to-earnings (P/E) ratio of 32.45, price-to-book of 8.45, price-to-sales of 8.72. Over the past 52 weeks the stock has ranged between $128.51 and $190.18, and currently trades 13.7% below its 52-week high. It pays a dividend yielding 1.25%.

On profitability, HOYA Corporation generates a return on equity (ROE) of 26.25% — well above the market average, a sign of a high-quality business, return on capital employed of 26.77%, an operating margin of 30.18%, a net profit margin of 27.16%.

In its most recent fiscal year, HOYA Corporation reported annual revenue of $1.00T, net profit of $268.3B, revenue has compounded at 12.5% a year over the last five years, profit at 16.4% a year. Profit growing faster than revenue points to expanding margins.

The balance sheet shows a debt-to-equity ratio of 0.04 — a conservative balance sheet with little leverage risk, a current ratio of 4.91, total assets of $1.31T, $576.6B in cash and equivalents.

HOCPY has an average daily trading volume of 39,416.9 shares, a beta of 0.97.

Official website: www.hoya.com

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides